ABCM logo

Abcam plc Stock Price

NasdaqGS:ABCM Community·US$5.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ABCM Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

ABCM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

2 Risks
1 Reward

Abcam plc Key Details

UK£379.7m

Revenue

UK£91.6m

Cost of Revenue

UK£288.1m

Gross Profit

UK£285.6m

Other Expenses

UK£2.5m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
0.011
75.88%
0.66%
16.4%
View Full Analysis

About ABCM

Founded
1998
Employees
1760
CEO
Alan Hirzel
WebsiteView website
www.abcam.com

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company’s principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Recent ABCM News & Updates

Recent updates

No updates